510
Views
0
CrossRef citations to date
0
Altmetric
Discussion

Advancing opioid stewardship in low-middle-income countries: challenges and opportunities

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance. (2014). American Journal of Health-System Pharmacy, 71(3), 243–246. https://doi.org/10.2146/sp140002
  • American Hospital Association. (2017). Stem the tide: Addressing the opioid epidemic. AHA. www.aha.org/opioidtoolkit
  • Azadfard, M., Huecker, M. R., & Leaming, J. M. (2021). Opioid addiction. In StatPearls [Internet]. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK448203/
  • Babar, Z. U. (2021). Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs). Journal of Pharmaceutical Policy and Practice, 14(1), 6. https://doi.org/10.1186/s40545-020-00288-2
  • Bach, P., & Hartung, D. (2019). Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. Addiction Science & Clinical Practice, 14(1), 30. https://doi.org/10.1186/s13722-019-0158-0
  • Bachhuber, M. A., Tuazon, E., Nolan, M. L., Kunins, H. V., & Paone, D. (2019). Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City. Pharmacoepidemiology and Drug Safety, 28(5), 734–739. https://doi.org/10.1002/pds.4766
  • Benyamin, R., Trescot, A. M., Datta, S., Buenaventura, R., Adlaka, R., Sehgal, N., Glaser, S. E., & Vallejo, R. (2008). Opioid complications and side effects. Pain Physician, 11(2 Suppl), S105–S120. https://doi.org/10.36076/ppj.2008/11/S105
  • Bicket, M. C., Brat, G. A., Hutfless, S., Wu, C. L., Nesbit, S. A., & Alexander, G. C. (2019). Optimizing opioid prescribing and pain treatment for surgery: Review and conceptual framework. American Journal of Health-System Pharmacy, 76(18), 1403–1412. https://doi.org/10.1093/ajhp/zxz146
  • Brown, R., & Morgan, A. (2019). The opioid epidemic in North America: Implications for Australia. Trends and Issues in Crime and Criminal Justice, 578, 1–15.
  • Bruera, E. (2018). Parenteral opioid shortage – Treating pain during the opioid-overdose epidemic. New England Journal of Medicine, 379(7), 601–603. http://doi.org/10.1056/NEJMp1807117
  • Budhathoki, S. S., Pokharel, P. K., Good, S., Limbu, S., & Bhattachan, M. (2017). Osborne RH: The potential of health literacy to address the health related UN sustainable development goal 3 (SDG3) in Nepal: A rapid review. BMC Health Services Research, 17(1), 237. https://doi.org/10.1186/s12913-017-2183-6
  • Cernasev, A., Hohmeier, K. C., Frederick, K., Jasmin, H., & Gatwood, J. (2021). A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder. Exploratory Research in Clinical and Social Pharmacy, 2, 100029.
  • Cheetham, A., Picco, L., Barnett, A., Lubman, D. I., & Nielsen, S. (2022). The impact of stigma on people with opioid use disorder, opioid treatment, and policy. Substance Abuse and Rehabilitation, 13, 1–12. https://doi.org/10.2147/SAR.S304566
  • Chen, A., Legal, M., Shalansky, S., Mihic, T., & Su, V. (2021). Evaluating a pharmacist-led opioid stewardship initiative at an urban teaching hospital. The Canadian Journal of Hospital Pharmacy, 74(3), 248–255.
  • Chisholm-Burns, M. A., Spivey, C. A., Sherwin, E., Wheeler, J., & Hohmeier, K. (2019). The opioid crisis: Origins, trends, policies, and the roles of pharmacists. American Journal of Health-System Pharmacy, 76(7), 424–435. https://doi.org/10.1093/ajhp/zxy089
  • Cid, A., Ng, A., & Ip, V. (2023). Addressing the opioid crisis-the need for a pain management intervention in community pharmacies in Canada: A narrative review. Pharmacy (Basel), 11(2).
  • Connery, H. S. (2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Review of Psychiatry, 23(2), 63–75. https://doi.org/10.1097/HRP.0000000000000075
  • Copello, A., Templeton, L., Orford, J., & Velleman, R. (2010). The 5-step method: Evidence of gains for affected family members. Drugs: Education, Prevention and Policy, 17(sup1), 100–112. https://doi.org/10.3109/09687637.2010.514234
  • Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., & Larney, S. (2019). Global patterns of opioid use and dependence: Harms to populations, interventions, and future action. The Lancet, 394(10208), 1560–1579. https://doi.org/10.1016/S0140-6736(19)32229-9
  • Delcher, C., Pauly, N., & Moyo, P. (2020). Advances in prescription drug monitoring program research: A literature synthesis (June 2018 to December 2019). Current Opinion in Psychiatry, 33(4), 326–333. https://doi.org/10.1097/YCO.0000000000000608
  • Dolovich, L., Austin, Z., Waite, N., Chang, F., Farrell, B., Grindrod, K., Houle, S., McCarthy, L., MacCallum, L., & Sproule, B. (2019). Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people's lives in the context of health care trends, evidence and policies. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 152(1), 45–53. https://doi.org/10.1177/1715163518815717
  • Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022). CDC clinical practice guideline for prescribing opioids for pain – United States, 2022. MMWR Recommendations and Reports, 71(3), 1–95. https://doi.org/10.15585/mmwr.rr7103a1
  • Drug Enforcement Administration. (2022). DEA teams up with more than 4,300 partners to remove unneeded prescription medications from communities. https://www.dea.gov/press-releases/2022/11/14/dea-teams-more-4300-partners-remove-unneeded-prescription-medications
  • Egan, K. L., Gregory, E., Sparks, M., & Wolfson, M. (2017). From dispensed to disposed: Evaluating the effectiveness of disposal programs through a comparison with prescription drug monitoring program data. The American Journal of Drug and Alcohol Abuse, 43(1), 69–77. https://doi.org/10.1080/00952990.2016.1240801
  • Eser, N., & Çelik, N. (2022). Association between rational drug use and health literacy among pregnant women: A cross-sectional study. Women & health, 62(7), 612–620. https://doi.org/10.1080/03630242.2022.2100033
  • Gondora, N., Versteeg, S. G., Carter, C., Bishop, L. D., Sproule, B., Turcotte, D., Halpape, K., Beazely, M. A., Dattani, S., Kwong, M., Nissen, L., & Chang, F. (2022). The role of pharmacists in opioid stewardship: A scoping review. Research in Social and Administrative Pharmacy, 18(5), 2714–2747. https://doi.org/10.1016/j.sapharm.2021.06.018
  • Gregory, T., & Gregory, L. (2020). The role of pharmacists in safe opioid dispensing. Journal of Pharmacy Practice, 33(6), 856–862. https://doi.org/10.1177/0897190019852803
  • Harding, R., & Higginson, I. J. (2005). Palliative care in sub-Saharan Africa. The Lancet, 365(9475), 1971–1977. https://doi.org/10.1016/S0140-6736(05)66666-4
  • HHS. (2019). HHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics. https://www.hhs.gov/system/files/Dosage_Reduction_Discontinuation.pdf
  • International Agency for Research on Cancer. (2018). Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. https://www.iarc.who.int/featured-news/latest-global-cancer-data-cancer-burden-rises-to-18-1-million-new-cases-and-9-6-million-cancer-deaths-in-2018.
  • Kerschbaum, E., & Nüssler, V. (2019). Cancer prevention with nutrition and lifestyle. Visceral Medicine, 35(4), 204–209. https://doi.org/10.1159/000501776
  • Knapp, C., Woodworth, L., Wright, M., Downing, J., Drake, R., Fowler-Kerry, S., Hain, R., & Marston, J. (2011). Pediatric palliative care provision around the world: A systematic review. Pediatric Blood & Cancer, 57(3), 361–368. https://doi.org/10.1002/pbc.23100
  • Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36(1), 559–574. https://doi.org/10.1146/annurev-publhealth-031914-122957
  • Krashin, D., Trescot, A., & Murinova, N. (2013). Opioids and pain treatment. In K. G. Ramawat & J.-M. Mérillon (Eds.), Natural products: Phytochemistry, botany and metabolism of Alkaloids, phenolics and terpenes (pp. 1367–1382). Springer Berlin Heidelberg.
  • McCabe, S. E., West, B. T., Veliz, P., McCabe, V. V., Stoddard, S. A., & Boyd, C. J. (2017). Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976–2015. Pediatrics, 139(4). https://doi.org/10.1542/peds.2016-2387
  • McGovern, R., Smart, D., Alderson, H., Araújo-Soares, V., Brown, J., Buykx, P., Evans, V., Fleming, K., Hickman, M., Macleod, J., Meier, P., & Kaner, E. (2021). Psychosocial interventions to improve psychological, social and physical wellbeing in family members affected by an adult relative's substance use: A systematic search and review of the evidence. International Journal of Environmental Research and Public Health, 18(4), 1793. https://doi.org/10.3390/ijerph18041793
  • Miller, R., & Goodman, C. (2016). Performance of retail pharmacies in low- and middle-income Asian settings: A systematic review. Health Policy and Planning, 31(7), 940–953. https://doi.org/10.1093/heapol/czw007
  • Nahin, R. L., Boineau, R., Khalsa, P. S., Stussman, B. J., & Weber, W. J. (2016). Evidence-based evaluation of complementary health approaches for pain management in the United States. Mayo Clinic Proceedings, 91(9), 1292–1306. https://doi.org/10.1016/j.mayocp.2016.06.007
  • National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. (2017). Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use. https://pubmed.ncbi.nlm.nih.gov/29023083/
  • National Institute on Drug Abuse. (2023). Drug overdoes death rates. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
  • NEJM Knowledge+ Team. (2020). Non-opioid analgesics role in pain management. NEJM Knowledge+. https://knowledgeplus.nejm.org/blog/non-opioid-analgesics-role-in-pain-management/
  • Noncommunicable diseases. (2023). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  • Norn, S., Kruse, P. R., & Kruse, E. (2005). History of opium poppy and morphine. Dansk Medicinhistorisk Arbog, 33, 171–184.
  • Opioid Use Disorder. (2024). Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/opioid-use-disorder
  • Pathan, H., & Williams, J. (2012). Basic opioid pharmacology: An update. British Journal of Pain, 6(1), 11–16. https://doi.org/10.1177/2049463712438493
  • Popovici, I., Maclean, J. C., Hijazi, B., & Radakrishnan, S. (2018). The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment. Health Economics, 27(2), 294–305. https://doi.org/10.1002/hec.3548
  • Rane, A., Church, S., Bhatia, U., Orford, J., Velleman, R., & Nadkarni, A. (2017). Psychosocial interventions for addiction-affected families in low and middle income countries: A systematic review. Addictive Behaviors, 74, 1–8. https://doi.org/10.1016/j.addbeh.2017.05.015
  • Rosen, Y. (2023). Opioid education program for grades 6 to 12 considered by Alaska lawmakers. Alaska Beacon, March 6. https://alaskabeacon.com/briefs/opioid-education-program-for-grades-6-to-12-considered-by-state-lawmakers/
  • Rosenblum, A., Marsch, L. A., Joseph, H., & Portenoy, R. K. (2008). Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Experimental and Clinical Psychopharmacology, 16(5), 405–416. https://doi.org/10.1037/a0013628
  • Rural Health Information Hub. (2020). Proper drug disposal programs. https://www.ruralhealthinfo.org/toolkits/substance-abuse/2/harm-reduction/drug-disposal
  • Sapkota, B., Giri, A., Bhatta, B., Awasthi, K., Bhurtyal, K., Joshi, B., & Joshi, K. R. (2022). Implementation of medicine take-back concept at community level in Nepal: A pilot study. Journal of Public Health, 44(3), 575–585. https://doi.org/10.1093/pubmed/fdab134
  • Sasaki, H., Bouesseau, M. C., Marston, J., & Mori, R. (2017). A scoping review of palliative care for children in low- and middle-income countries. BMC Palliative Care, 16(1), 60. https://doi.org/10.1186/s12904-017-0242-8
  • Schwartz, R. P., Gryczynski, J., O'Grady, K. E., Sharfstein, J. M., Warren, G., Olsen, Y., Mitchell, S. G., & Jaffe, J. H. (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. American Journal of Public Health, 103(5), 917–922. https://doi.org/10.2105/AJPH.2012.301049
  • Shrestha, R., & Shrestha, S. (2024). Addressing the critical gap: Ensuring urgent access to palliative care services with essential medications in Nepal. Journal of Pain & Palliative Care Pharmacotherapy, 1–10. http://doi.org/10.1080/15360288.2024.2320384
  • Shrestha, S., Iqbal, A., Teoh, S. L., Khanal, S., Gan, S. H., Lee, S. W. H., & Paudyal, V. (2024). Impact of pharmacist-delivered interventions on pain-related outcomes: An umbrella review of systematic reviews and meta-analyses.  Research in Social and Administrative Pharmacy, S1551-7411(24)00091-3. https://doi.org/10.1016/j.sapharm.2024.03.005
  • Shrestha, S., Kc, B., Blebil, A. Q., & Teoh, S. L. (2022). Pharmacist involvement in cancer pain management: A systematic review and meta-analysis. The Journal of Pain, 23(7), 1123–1142. https://doi.org/10.1016/j.jpain.2022.02.002
  • Shrestha, S., Khatiwada, A. P., Gyawali, S., Shankar, P. R., & Palaian, S. (2020). Overview, challenges and future prospects of drug information services in nepal: A reflective commentary. Journal of Multidisciplinary Healthcare, 13, 287–295. https://doi.org/10.2147/JMDH.S238262
  • Shrestha, S., Khatiwada, A. P., Sapkota, B., Sapkota, S., Poudel, P., Kc, B., Teoh, S. L., Blebil, A. Q., & Paudyal, V. (2023). What is "opioid stewardship"? An overview of current definitions and proposal for a universally acceptable definition. Journal of Pain Research, 16, 383–394. https://doi.org/10.2147/JPR.S389358
  • Smith, R. G. (2020). A process review to an interdisciplinary approach to opioid stewardship. Journal of Interprofessional Education & Practice, 20, 100344. https://doi.org/10.1016/j.xjep.2020.100344
  • Soltani, H., & Pardakhty, A. (2016). Marketed new drug delivery systems for opioid agonists/antagonists administration: A rapid overview. Addiction & Health, 8(2), 115–122.
  • Thakur, T., Frey, M., & Chewning, B. (2021). Communication between patients and health care professionals about opioid medications. Exploratory Research in Clinical and Social Pharmacy, 2, 100030.
  • Thapa, P., Lee, S. W. H., KC, B., Dujaili, J. A., Mohamed Ibrahim, M. I., & Gyawali, S. (2021). Pharmacist-led intervention on chronic pain management: A systematic review and meta-analysis. British Journal of Clinical Pharmacology, 87(8), 3028–3042. https://doi.org/10.1111/bcp.14745
  • The Frontline in the Fight Against Addiction. (2024). https://searidgedrugrehab.com/article/pharmacies-recovery/
  • Trang, T., Al-Hasani, R., Salvemini, D., Salter, M. W., Gutstein, H., & Cahill, C. M. (2015). Pain and poppies: The good, the bad, and the ugly of opioid analgesics. The Journal of Neuroscience, 35(41), 13879–13888. https://doi.org/10.1523/JNEUROSCI.2711-15.2015
  • UNODC. (2023). Drivers of Illicit Trafficking in Border Communities in Southeast Asia.
  • Uritsky, T. J., Busch, M. E., Chae, S. G., & Genord, C. (2021). Opioid stewardship: Building on antibiotic stewardship principles (Vol. 34, pp. 181–183). Taylor & Francis.
  • Veettil, S. K., Darouiche, G., Sawangjit, R., Cox, N., Lai, N. M., & Chaiyakunapruk, N. (2022). Effects of pharmacist interventions on pain intensity: Systematic review and meta-analysis of randomized controlled trials. Journal of the American Pharmacists Association, 62(4), 1313–1320.e1316. https://doi.org/10.1016/j.japh.2022.02.015
  • Velleman, R., Orford, J., Templeton, L., Copello, A., Patel, A., Moore, L., Macleod, J., & Godfrey, C. (2011). 12-month follow-up after brief interventions in primary care for family members affected by the substance misuse problem of a close relative. Addiction Research & Theory, 19(4), 362–374. https://doi.org/10.3109/16066359.2011.564691
  • Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156(4), 569–576. https://doi.org/10.1097/01.j.pain.0000460357.01998.f1
  • Webb, K., Cernasev, A., Li, M. S., Gatwood, J., Cochran, G., & Hohmeier, K. C. (2021). An exploratory study of pharmacist perceptions of opioid interventions for acute pain. Journal of Pharmacy Technology, 37(1), 36–44. https://doi.org/10.1177/8755122520967766
  • WHO. (2023). Opioid overdose. https://www.who.int/news-room/fact-sheets/detail/opioid-overdose
  • Wu, P. E., Lee, T. C., & McDonald, E. G. (2023). What should i know about medication deprescribing? JAMA Internal Medicine, 183(8), 891–891. https://doi.org/10.1001/jamainternmed.2023.2099